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Recent reports on the abuse of novel synthetic cathinone derivatives call attention
to serious public health risks of these substances. In response to this concern, a growing
body of preclinical research has characterized the psychopharmacology of these
substances, particularly mephedrone (MEPH) or methylenedioxypyrovalerone (MDPV),
noting their similarities to MDMA and cocaine. The present study employed drug
discrimination methodology to assess the discriminative stimulus effects of MEPH and
MDPV in male Sprague-Dawley rats trained to discriminate 1.5 mg/kg 3,4
methylenedioxymethamphetamine (MDMA) or a mixture of 1.5 mg/kg MDMA and 0.5
mg/kg d-amphetamine (MDMA+AMPH). After establishing dose response functions
with each training drug, MDPV (0.25-2.0 mg/kg), mephedrone (0.25-2.0 mg/kg), and
cocaine were evaluated for substitution. Dose response curves generated with MDMA
and MEPH were comparable between training groups. In contrast, AMPH, MDPV, and
cocaine produced only partial substitution in animals trained to discriminate MDMA but
produced full substitution in animals trained to discriminate the MDMA+AMPH mixture.
These findings indicate MDPV’s effects may be more similar to those of traditional
psychostimulants, whereas MEPH exerts stimulus effects more similar to those of
MDMA.

Copyright by
Eric Louis Harvey
2015

ACKNOWLEDGEMENTS

I would like to thank all those members of the Baker and Poling labs who
contributed their time and effort in helping me on this project. A special thank you to Dr.
Amanda Quisenberry for teaching me the skills and techniques needed in drug
discrimination research.
Secondly, I wish to thank my committee members, Dr. Lisa Baker, Dr. Alan
Poling, and Dr. Bradley Huitema for their time in reviewing and critiquing my thesis. I
would especially like to thank my advisor, Dr. Lisa Baker, for her invaluable guidance
and feedback during both the data collection and writing processes, and without whom
none of this research would have been possible.
Finally, I would like to thank my family and friends for their continued support
during my education and who made it possible for me to be where I am today.
Aut inveniam viam aut faciam

Eric Louis Harvey

ii

TABLE OF CONTENTS
ACKNOWLEDGEMENTS ................................................................................................ ii
LIST OF FIGURES ........................................................................................................... iv
Introduction ......................................................................................................................... 1
Methods............................................................................................................................... 4
Subjects ........................................................................................................................... 4
Drugs ............................................................................................................................... 5
Preliminary Training ....................................................................................................... 6
Discrimination Training .................................................................................................. 7
Stimulus Generalization Tests ........................................................................................ 7
Data Analysis .................................................................................................................. 8
Results ................................................................................................................................. 9
Discrimination Acquisition ............................................................................................. 9
Stimulus Generalization .................................................................................................. 9
Discussion ......................................................................................................................... 15
References ......................................................................................................................... 19
Appendix ........................................................................................................................... 24
IACUC Protocol Approval Letter ................................................................................. 24

iii

LIST OF FIGURES

1. Dose response curves determined from stimulus generalization tests with
MDMA, d-amphetamine, and cocaine…………………………………………….

10

2. Dose response curves determined from stimulus generalization tests with
(+)-MDMA, mephedrone, and MDPV……………………………………………. 11

iv

Introduction
Recent reports have noted a marked increase in the use of recreational “designer
drugs” in the United States and Europe (Gibbons & Zloh, 2010; Rosenbaum et al., 2012).
Of particular concern is the emergence and growing popularity of synthetic cathinone
derivatives. Cathinone is the naturally occurring amphetamine-like alkaloid found in
Catha edulis (Khat), a plant native to Africa and the Middle East. Although the extracts
of Khat leaves have been used for centuries for their psychostimulant properties, medical
and law enforcement reports of serious toxicities associated with synthetic cathinone
derivatives have appeared only within the last decade in the U.S. (Goodnough & Zezima,
2011; Winstock & Ramsey, 2010).
The emergence of this public health threat began in the mid to late 2000s, when
synthetic cathinones gained popularity among recreational drug users. Presumably as a
method of diversion and evasion of FDA regulations, mixtures of synthetic cathinones
were falsely marketed under a variety of product descriptions, such as “bath salts”, “plant
food”, and “research chemicals”. Toxicities resulting from use of these products have
received widespread media attention, including reports of violent and bizarre behavior
(e.g. Campbell, 2012; "Police: Man on," 2013). In response to a growing public health
concern, several of the chemical constituents of these products and their analogs are now
classified as Schedule I controlled substances in the United States (DEA, 2011).
The chemical constituents of “bath salts” include several synthetic cathinone
derivatives, presenting a considerable challenge to medical and scientific investigations
1

to determine which of these chemicals pose the greatest health threat. However,
according to a recent report by the DEA, mephedrone (4-methlymethcathinone or 4MMC), methylenedioxypyrovalerone (MDPV), and methylone (3,4methylenedioxymethylcathinone) account for approximately 98% of all synthetic
cathinones encountered by law enforcement agencies (DEA, 2011). There is now a
growing body of literature devoted to preclinical investigations of the
neuropharmacological and behavioral effects of synthetic cathinones. The majority of
these studies have examined the effects of either mephedrone or MDPV, although a few
have also included other cathinone derivatives (Wright et al., 2012; Baumann et al., 2012;
Huang et al., 2012; Lisek et al., 2012; Motbey, 2012; Aarde et al., 2013; Varner et al.,
2013; Shortall et al., 2013; Fantegrossi et al., 2013; Gatch et al., 2013). It is now well
established that these substances dose-dependently increase locomotor activity in rodents.
Furthermore, repeated daily dosing with mephedrone for five to seven days (Lisek et al.,
2012; Gregg et al., 2013a; Berquist et al., 2015) as well as repeated intermittent dosing
(Shortall et al., 2013) produced behavioral sensitization in rodents. Additionally, at least
one study demonstrated cross-sensitization to the acute locomotor effects of cocaine (15
mg/kg) 10 days after a five day treatment regimen with mephedrone (15 mg/kg) in rats
(Gregg et al., 2013b), although this effect was not bidirectional. Mephedrone (30 mg/kg)
has also been shown to produce conditioned place preference (CPP) in both rats and mice
(Lisek et al., 2012) and methylone was reported to produce CPP in mice (Miyazawa et
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al., 2011). Moreover, mephedrone supports intravenous self-administration in rats (Aarde
et al., 2013).
Drug discrimination methodology is commonly employed to characterize the
neuropharmacological actions of novel psychoactive substances. Drugs sharing similar
discriminative functions in nonhumans also tend to have common psychoactive effects
(i.e. intoxicating effects) in humans (Young, 2009). Moreover, drugs that are determined
to have similar discriminative stimulus properties can be predicted to share some
pharmacological mechanisms of action as well as similar abuse liabilities (Nicholson &
Balster, 2001). To date, four published studies have examined one or more of the
synthetic cathinones using drug discrimination methodology with rodents. Methylone
was reported to substitute fully in rats trained to discriminate d-amphetamine or MDMA
from saline, but not in rats trained to discriminate DOM from saline (Dal Cason et al.,
1997). More recently, Gatch et al. (2013) reported that several cathinone derivatives
(MDPV, mephedrone, flephedrone, naphyrone, methylone, and butylone) all produced
dose-dependent increases in drug-lever responding and fully substituted in male SpragueDawley rats trained to discriminate either cocaine (10 mg/kg) or methamphetamine (1
mg/kg). Varner et al. (2013) reported that male Long Evans hooded rats successfully
acquired discrimination of 3.2 mg/kg mephedrone. Only MDMA and mephedrone
produced complete substitution, while 18 mg/kg cocaine (76%) and 1 mg/kg
methamphetamine (73%) produced partial substitution. Fantegrossi et al. (2013)
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demonstrated full substitution with MDMA and methamphetamine in male NIH Swiss
mice trained to discriminate 0.3 mg/kg MDPV from saline.
In consideration of the fact that most psychoactive have complex stimulus
functions involving several pharmacological mechanisms, drug discrimination procedures
have been utilized by some researchers to evaluate the effects of drug mixtures in
comparison to novel substances as a way to assess distinct components of a drug’s
complex stimulus functions (Stolerman, 2011). The goal of the present study was to
compare stimulus generalization with the synthetic cathinones, MDPV and mephedrone,
in rats trained to discriminate either a drug mixture (d-amphetamine + MDMA) or a
single drug (MDMA).
Methods
Subjects
Sixteen adult male Sprague-Dawley rats were housed individually in
polycarbonate cages lined with corn cob bedding (Harlan Teklad, Conrad, Iowa) in
animal facilities maintained at constant temperature (20±2°C) and humidity (50±5%)
under a 12:12 light/dark cycle, (lights on from 0900 to 2100). Water was provided ad
libitum in the home cages. Commercial rodent diet (Purina® 5001, Richmond, Indiana)
was restricted to daily feeding to maintain animals at 80-90% of free-feeding weights.
All procedures were reviewed and approved by the Western Michigan University
Institutional Animal Care and Use Committee and were in accordance with the guidelines
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of the Guide for the Care and Use of Laboratory Animals (National Academy of
Sciences, 2011) and EU Directive 2010/63/EU.
Apparatus: Training and testing were conducted in eight sound-attenuated operant
conditioning chambers (ENV-001; MED Associates Inc., Georgia, VT, USA) equipped
with three removable levers and a food pellet dispenser located on the front panel, a 28-V
house light, and fan. Reinforcers for lever pressing consisted of 45 mg Dustless Precision
Pellets® (Product# F0021, BioServ, Flemington, NJ). Experimental events were
programmed and controlled using Med-PC software (version IV; MED Associates Inc.,
St. Albans, VT, USA).
Drugs
Mephedrone-hydrochloride, 3,4-methylenedioxypyrovalerone-hydrochloride,
cocaine-hydrochloride, and 3,4-methylenedioxymethamphetamine-hydrochloride were
generously provided by the National Institute on Drug Abuse drug control supply
program (Bethesda, MD). d-Amphetamine-hemisulfate was purchased from Sigma
Chemical Company (St Louis, MO). All drugs were dissolved in bacteriostatic 0.9%
sodium chloride with a constant injection volume of 1ml/kg administered by
intraperitoneal (i.p.) injection. For the training drug mixture of d-amphetamine and
MDMA, these substances were dissolved together in a single solution. Doses were
calculated based on the weights of the salts.
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Preliminary Training
Subjects were acclimated to the operant chambers for two 60 minute sessions, one
per day for two consecutive days. During these acclimation sessions, no levers were
extended and food pellets were delivered under a fixed-time 60 sec (FT60ʺ) schedule to
familiarize the animals with the location of the food magazine and sound of the pellet
dispenser. Subsequent training sessions lasted 20 min per day and were conducted five to
six days per week. Animals were initially trained to lever press with only the center lever
extended and reinforcement was delivered under a fixed-ratio (FR) schedule that was
gradually incremented from FR 1 to FR 20 over the course of seven training sessions.
Once subjects were reliably lever pressing on the FR 20 schedule, errorless training
sessions were conducted with either the left lever or right lever extended. During this
phase, subjects received injections of either the training drug (see below) or saline 10 min
prior to the beginning of each session. Half the animals in each training group were
reinforced for responses on the right lever following drug injections and for responses on
the left lever following saline injections. Conditions were reversed for the remaining
animals in each group. A total of 12 errorless training sessions were conducted in the
following order: V, V, D, D, V, D, V, V, D, D, V, D. Once subjects were responding
reliably on an FR20 schedule for both the drug-paired and vehicle-paired levers,
discrimination training commenced.
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Discrimination Training
Both the left and right levers were present during discrimination training sessions.
These sessions were 20 min in duration and were conducted only once per day, five to six
days a week. One group of rats (n=7) was trained to discriminate 1.5 mg/kg MDMA from
saline injections and the other group (n=8) was trained to discriminate a mixture of 1.5
mg/kg MDMA + 0.5 mg/kg d-amphetamine from saline injections. Similar to the
preliminary training sessions, responding was initially reinforced under a FR1 schedule
that was progressively incremented to a FR20 schedule under drug and vehicle
conditions, independently based on each subject’s performance. Once animals were
reliably responding under the FR20 schedule under both drug and vehicle conditions, this
schedule remained in effect for the remainder of the training sessions. Drug and vehicle
training sessions were alternated with sessions under the same stimulus conditions
occurring no more than twice consecutively. The performance criteria for stimulus
control was a minimum of 8 out of 10 consecutive discrimination trials with an 80% or
better correct lever response prior to delivery of the first reinforcer and for the total
session.
Stimulus Generalization Tests
When the discrimination criteria were met, stimulus generalization tests
commenced and dose-response curves were established with the following test
compounds: MDMA (0.19 – 1.5 mg/kg), AMPH (0.25 – 2.0 mg/kg), cocaine (1.25 – 10
mg/kg), (+)-MDMA (0.375 – 3.0 mg/kg), mephedrone (0.25 – 2.0 mg/kg), and MDPV
7

(0.13 – 3.0 mg/kg). All compounds were administered 10 min prior to each test session.
Test sessions were conducted under extinction and ended immediately following the
completion of 20 consecutive responses on either lever or when 20 min elapsed, which
ever occurred first. The order of the test doses were counterbalanced among animals in
each training group. Approximately half of the animals in each group were tested with a
particular dose following a drug training session, and the other half was tested following
a vehicle training session. Each subject completed a minimum of one drug and one
vehicle training session between generalization test sessions and was required to meet the
80% discrimination criteria on the most recent drug and vehicle training sessions prior to
each test.
Data Analysis
The mean (±SEM) number of sessions to criterion was calculated for each
training group and statistically analyzed with a t-test. Dose-response curves were graphed
for each training drug and test compound, with the mean (±SEM) percentage of drugappropriate lever responses as well as the mean (±SEM) response rate (lever presses per
second) plotted as a function of dose. Data from subjects completing test sessions with all
doses of a compound were statistically evaluated using a mixed model two-way analysis
of variance (ANOVA) with training drug as a between subjects comparison and test dose
as a within subjects comparison. For drugs that produced full substitution (80% or higher
drug-lever responding at any dose), a nonlinear regression was conducted on the dose-
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response curve to estimate ED50 values. Statistical analyses were conducted and graphs
were created using GraphPad Prism (version 6.0) software (La Jolla, CA, USA).
Results
Discrimination Acquisition
Rats trained to discriminate MDMA+AMPH met the specified criteria for
discrimination within 16.9 (±0.4, SEM) training sessions (range 16 – 19) while rats
trained to discriminate MDMA met these criteria in an average of 29.1 (±4.4, SEM)
training sessions (range 16 – 43). This difference was statistically significant (t(6.1) =
2.781, p < 0.05). Interestingly, there was a bimodal distribution in the sessions to criteria
among the MDMA training group, with a range of 16 to 18 sessions among three animals
and a range of 35 to 43 sessions among the other four animals.
Stimulus Generalization
Dose response curves for MDMA, AMPH, and cocaine are displayed in Figure 1.
Dose response curves for (+)-MDMA, mephedrone, and MDPV are displayed in Figure
2. MDMA produced a dose-dependent increase in drug-appropriate responding and
substituted fully at 1.5 mg/kg in both MDMA-trained and MDMA+AMPH-training
groups. A two-factor mixed model ANOVA showed a statistically significant effect of
MDMA dose on the percentage of drug-lever responding (F4, 52 = 23.96, p = < 0.001),
although there was no significant effect of training group, nor was there a significant
training group by test dose interaction. Bonferroni multiple comparison tests indicated
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that the 0.75 and 1.5 mg/kg doses in both groups, as well as the 0.19 mg/kg dose in the
MDMA training group, were significantly different from saline (p < 0.05).

Figure 1. Dose response curves determined from stimulus generalization tests with
MDMA, d-amphetamine, and cocaine in rats trained to discriminate a 1.5 mg/kg MDMA
(n = 7) or a mixture of 1.5 mg/kg MDMA + 0.5 mg/kg amphetamine (n = 8) from saline.
Graphs in the upper panel depict percentage of responses on the drug-appropriate lever.
Graphs in the lower panel depict response rate. Individual points represent group means
(± S.E.M.). MDMA+AMPH mixture group (■) and MDMA alone group (●). Significant
Bonferroni multiple comparison tests between selected doses and saline are represented
by * (p<0.05), ** (p < 0.01), and # (p< 0.001).
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Figure 2. Dose response curves determined from stimulus generalization tests with (+)MDMA, mephedrone, and MDPV in rats trained to discriminate a 1.5 mg/kg MDMA (n
= 7) or a mixture of 1.5 mg/kg MDMA + 0.5 mg/kg amphetamine (n = 8) from saline.
Graphs in the upper panel depict percentage of responses on the drug-appropriate lever.
Graphs in the lower panel depict response rate. Individual points represent group means
(± S.E. M.). MDMA+AMPH mixture group (■) and MDMA alone group (●). Significant
Bonferroni multiple comparison tests between selected doses and saline are represented
by * (p<0.05), ** (p < 0.01), and # (p< 0.001).

The ED50 values for MDMA were 0.21 mg/kg (95% CI [0.12 – 0.37 mg/kg]) and 0.35
mg/kg (95% CI [0.15 – 0.82 mg/kg]) in the MDMA+AMPH and the MDMA training
groups respectively. A two-factor mixed model ANOVA also showed a statistically
significant main effect of test dose on response rate (F4, 52 = 5.56, p < 0.001). There was
no statistically significant effect of training group nor was there a significant training
11

group by test dose interaction on response rate. Bonferroni multiple comparison tests
indicated 1.5 mg/kg was significantly different from saline (p < 0.05) only in the
MDMA-trained animals.
d-Amphetamine (AMPH) also produced a dose-dependent increase in drugappropriate responding in both training groups. However, full substitution was observed
in the MDMA+AMPH training group at 0.5, 1.0 and 2.0 mg/kg, whereas only partial
substitution was observed in the MDMA training group. A two-factor mixed model
ANOVA excluded data from two animals in the MDMA group and one animal in the
MDMA+AMPH group that failed to respond following the 2.0 mg/kg dose. AMPH
produced a statistically significant effect on the percentage of drug-lever responding (F4,
40

= 7.07, p < 0.001). A significant difference between training groups on drug-lever

responding was also found (F1, 10 = 11.34, p < 0.01), but there was no significant training
group by test dose interaction. Bonferroni multiple comparison tests revealed 0.25, 0.5 (p
< 0.01) and 1.0 mg/kg AMPH (p < 0.05) produced drug-appropriate responding that was
significantly different from saline in the MDMA+AMPH training group and none of the
multiple comparisons were statistically significant in the MDMA training group. The
ED50 for AMPH in the MDMA+AMPH training group was calculated at 0.06 mg/kg
(95% CI [0.03 – 0.14 mg/kg]). A two-factor mixed model ANOVA found that response
rate was significantly affected by test dose (F4, 52 = 15.91, p < 0.001). No significant
effects of training group or test dose by training group were found. Bonferroni multiple
comparison tests found the 2.0 mg/kg dose to be significantly different from saline in the
12

MDMA+AMPH training group (p < 0.001), and all but the 0.25 mg/kg dose to be
significantly different from saline in the MDMA training group (0.5 and 1.0 mg/kg, p <
0.05 and 2.0 mg/kg, p < 0.001).
Similar to AMPH, cocaine also produced only partial substitution in animals
trained to discriminate MDMA, but fully substituted in those trained to discriminate the
MDMA+AMPH mixture. A mixed model two factor ANOVA showed a statistically
significant main effect of cocaine dose on drug-lever responding (F4, 40 = 4.428, p <
0.01), although no significant effect of training group was observed, nor was there a
significant training group by test dose interaction. Bonferroni multiple comparisons
found that drug-appropriate responses were significantly different from saline in the
MDMA+AMPH training group at the 5.0 mg/kg (p < 0.05) and 10.0 mg/kg (p < 0.01)
doses. The ED50 value for animals trained to discriminate MDMA+AMPH was 4.65
mg/kg (95% CI [1.31 – 16.57 mg/kg]). A two-factor mixed model ANOVA also found a
significant main effect of test dose on response rates (F4, 40 = 3.70, p < 0.05). No
significant effects of training group or training group by test dose interaction were found.
Bonferroni multiple comparison tests found response rate at the 10.0 mg/kg dose to be
significantly lower than that of saline in the MDMA-trained group (p < 0.05).
The (+)-MDMA isomer produced a dose-dependent increase in drug-lever
responding, with full substitution in the MDMA training group at the 1.5 mg/kg dose, and
at the 3.0 mg/kg dose in both training groups. A two-factor mixed model ANOVA
excluded data from five animals in the MDMA group and one animal in the
13

MDMA+AMPH group that did not complete the 3.0 mg/kg dose and indicated a
significant main effect of (+)-MDMA dose on drug-lever responding (F4, 28 = 8.245, p <
0.001). No significant effects of training group or training group by test dose interaction
were shown. Bonferroni multiple comparisons found that drug-lever responding at the 1.5
mg/kg and 3.0 mg/kg doses was significantly different from vehicle in both
MDMA+AMPH group (p < 0.05 and p < 0.001, respectively). The ED50 values for (+)MDMA were calculated at 0.44 mg/kg (95% CI [0.17 to 1.12 mg/kg]) in the
MDMA+AMPH training group and 0.48 mg/kg (95% CI [0.19 to 1.19 mg/kg]) in the
MDMA training group. A two-factor mixed model ANOVA also showed a significant
main effect of (+)-MDMA dose on response rate (F4, 32 = 11.64, p < 0.001). Bonferroni
multiple comparison tests revealed response rate at the 3.0 mg/kg to be significantly
different from saline in both training groups (p < 0.001).
Mephedrone produced a dose-dependent increase in drug-appropriate responding
and full substitution at the 2.0 mg/kg dose in both training groups. A two-factor mixed
model ANOVA found a significant main effect of MEPH dose on drug-lever responding
(F4, 48 = 11.21, p < 0.001). No significant effects of training group or training group by
test dose interaction were shown. Bonferonni multiple comparisons revealed that druglever responding at the 2.0 mg/kg dose was significantly different from saline in both
training groups (p < 0.01). The ED50 values were calculated at 0.56 mg/kg (95% CI [0.25
– 1.23 mg/kg]) in the MDMA+AMPH training group and 0.22 mg/kg (95% CI [0.10 –
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0.49 mg/kg]) in the MDMA training group. A two-factor mixed model ANOVA revealed
no significant effects of MEPH on response-rate.
Dose response curves for MDPV were distinctly different in the two training
groups, similar to the distinction evident with cocaine and AMPH. As such, full
substitution with MDPV was attained only in the MDMA+AMPH training group. A
two-factor mixed model ANOVA found that the MDPV test dose had a significant effect
on percent drug-lever responding (F6, 66 = 7.77, p < 0.001). A significant test dose by
training group interaction was also found (F6, 66 = 3, p < 0.05), but there was no
statistically significant effect of training group alone. Bonferroni multiple comparison
tests showed that the 1.0 and 2.0 mg/kg doses were significantly different from saline in
the MDMA+AMPH training group (p < 0.001). The ED50 value for MDPV in the
MDMA+AMPH training group was calculated at 0.30 mg/kg (95% CI [0.11 – 0.82
mg/kg]). A two-factor mixed model ANOVA also showed a significant main effect of
MDPV dose on response rate (F5, 65 = 3.460, p < 0.01). Bonferroni multiple comparison
tests did not reveal any individual doses to be significantly different from saline in either
training group.
Discussion
As designer drugs continue to increase in popularity, due mostly to the ubiquity of
internet sources from which to obtain them, the potential adverse psychological effects of
these drugs are a growing public health concern. At the forefront of these new drugs are
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the many variations of the synthetic cathinones, with mephedrone and MDPV among the
most widely abused constituents and often found together in “bath salt” mixtures.
The primary finding of the present study is the differential substitution produced
by mephedrone and MDPV in animals trained to discriminate MDMA or a complex drug
mixture consisting of MDMA and d-amphetamine. Specifically, mephedrone produced
similar dose-dependent increases in responding and reached full substitution in both
training groups at the 2.0 mg/kg dose. Although not statistically significant, the ED50 of
mephedrone was approximately two-fold lower in the MDMA training group compared
to the MDMA+AMPH training group. In contrast, MDPV produced full substitution only
in the MDMA+AMPH training group, whereas a flat dose response curve and partial
substitution was obtained with MDPV in the MDMA only training group. It is possible
that higher MDPV doses could produce substitution for MDMA, although the rate
suppressant effects precluded testing higher doses of MDPV. In fact, 3.0 mg/kg produced
less substitution than 2.0 mg/kg in MDMA-trained animals, producing an inverted U
shaped dose response function.
The full substitution of mephedrone in both training groups suggests that this
substance produces similar interoceptive stimuli (i.e., subjective effects) to those
produced by MDMA (the component common to both training groups). This hypothesis
is consistent with self-reports by human subjects equating the subjective effects of
mephedrone to those of MDMA (Carhart-Harris et al., 2011). Moreover, recent reports
indicate the pharmacological mechanisms of action of mephedrone closely resemble
16

those of MDMA and are distinct from those of MDPV (Cameron et al., 2013; Bauman et
al., 2012; Kehr et al., 2011). For example, unlike MDPV, mephedrone produces
significant increases in serotonin (5-HT) release in rat nucleus accumbens in vivo (Kehr
et al. 2011; Baumann et al. 2012), whereas MDPV reported blocks dopamine reuptake,
similar to cocaine (Cameron et al., 2013).
Full substitution of MDPV only in the MDMA+AMPH training group, indicates
that MDPV produces interoceptive stimuli that are dissimilar to those produced by
MDMA alone and more similar to the amphetamine component of the MDMA+AMPH
mixture. This is supported by the current results that both AMPH and cocaine also
produced full substitution in the MDMA+AMPH training group, suggesting that
amphetamine was the dominant component of the complex stimulus cue.
Due to the apparent lack of overshadowing by either component in the
MDMA+AMPH mixture (i.e. both components of the mixture fully substituted
individually at their respective training doses), it can be concluded that the
MDMA+AMPH mixture does not produce a novel stimulus cue, but rather the
components likely have an additive effect. These findings may be compared to those of
Shoaib et al. (1997) who found that a mixture of fenfluramine (FEN) and phentermine
(PHEN) (agents with similar neurochemical effects to MDMA and amphetamine,
respectively) produced an additive cue in animals trained to discriminate a FEN+PHEN
mixture from saline.
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Insofar as drug discrimination offers a model of subjective drug effects, the
current results are relevant to distinguishing the subjective effects of mephedrone and
MDPV and the pharmacological actions contributing to these effects. Utilizing drug
mixtures as complex stimuli offers a novel approach to examine the pharmacological
mechanisms that may distinguish the subjective effects of mephedrone and MDPV. This
study represents the first attempt to do so. In consideration of the common practice of
polysubstance use, further investigations on the stimulus functions of drug mixtures may
help elucidate the unique subjective effects of commonly co-abused drugs.
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